The deal will give Zimmer Biomet access to Paragon's surgical implants and equipment used to treat foot and ankle ailments, while bolstering its fracture and trauma, and joint replacement businesses.

On Tuesday, the company inked a deal to be acquired by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) at around $1.1 billion in equity and $1.2 billion in enterprise value. Zimmer Biomet plans to ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Next ...

(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) agreed to acquire all outstanding shares of common stock of Paragon 28 Inc. (FNA) for an upfront payment of $13.00 per share in cash, corresponding to ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close Established in 2010, Paragon 28 has an ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo., Jan. 28, ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo., ...

These miniature implants require robust solutions to maintain stability and functionality throughout their operational lifespan. Atomic layer deposition (ALD) allows for precise control over film ...